These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
65 related articles for article (PubMed ID: 1490193)
21. Effect of back passage of Venezuelan equine encephalomyelitis vaccine (TC-83) on the central nervous system of horses. Monlux WS; Luedke AJ; Mercado S; Rosales JC J Am Vet Med Assoc; 1972 Oct; 161(7):832-3. PubMed ID: 5074265 [No Abstract] [Full Text] [Related]
22. Kinetics of cytokine expression and regulation of host protection following infection with molecularly cloned Venezuelan equine encephalitis virus. Grieder FB; Davis BK; Zhou XD; Chen SJ; Finkelman FD; Gause WC Virology; 1997 Jul; 233(2):302-12. PubMed ID: 9217054 [TBL] [Abstract][Full Text] [Related]
23. Specific restrictions in the progression of Venezuelan equine encephalitis virus-induced disease resulting from single amino acid changes in the glycoproteins. Grieder FB; Davis NL; Aronson JF; Charles PC; Sellon DC; Suzuki K; Johnston RE Virology; 1995 Feb; 206(2):994-1006. PubMed ID: 7856110 [TBL] [Abstract][Full Text] [Related]
25. [Evaluation of arbovirus attenuation by changes in the histamine level in the blood of immunized animals]. Beketova ZP; Vasil'eva OA Vopr Virusol; 1975; (2):151-5. PubMed ID: 1241175 [TBL] [Abstract][Full Text] [Related]
26. Venezuelan equine encephalomyelitis: antibody response in vaccinated horses and resistance to infection with virulent virus. Jochim MM; Barber TL; Luedke AJ J Am Vet Med Assoc; 1973 Feb; 162(4):280-3. PubMed ID: 4686185 [No Abstract] [Full Text] [Related]
27. Vascular clearance of venezuelan equine encephalomyelitis viruses as a correlate to virulence for rhesus monkeys. Jahrling PB; Hilmas DE; Heard CD Arch Virol; 1977; 55(1-2):161-4. PubMed ID: 411457 [TBL] [Abstract][Full Text] [Related]
29. Clinical studies of an attenuated virus cell culture venezuelan equine encephalomyelitis vaccine. Sampson GR; Elliston NG; Miyat JA; Grueter HP; Gillespie JR; Rathmacher RP Mod Vet Pract; 1973 Aug; 54(8):19, 21-2. PubMed ID: 4803525 [No Abstract] [Full Text] [Related]
30. Improved efficacy of a gene optimised adenovirus-based vaccine for venezuelan equine encephalitis virus. Williams AJ; O'Brien LM; Phillpotts RJ; Perkins SD Virol J; 2009 Jul; 6():118. PubMed ID: 19646224 [TBL] [Abstract][Full Text] [Related]
31. Pseudotyped viruses permit rapid detection of neutralizing antibodies in human and equine serum against Venezuelan equine encephalitis virus. Kolokoltsov AA; Wang E; Colpitts TM; Weaver SC; Davey RA Am J Trop Med Hyg; 2006 Oct; 75(4):702-9. PubMed ID: 17038698 [TBL] [Abstract][Full Text] [Related]
32. An attenuated mutant of Venezuelan encephalitis virus: biochemical alterations and their genetic association with attenuation. Emini EA; Wiebe ME Virology; 1981 Apr; 110(1):185-96. PubMed ID: 7210503 [No Abstract] [Full Text] [Related]
33. Venezuelan equine encephalomyelitis viral infection of newly hatched chickens and embryonating eggs. Dickerman RW; Bonacorsa CM Am J Vet Res; 1975 Aug; 36(08):1231-3. PubMed ID: 1155839 [TBL] [Abstract][Full Text] [Related]
34. Molecular evidence that epizootic Venezuelan equine encephalitis (VEE) I-AB viruses are not evolutionary derivatives of enzootic VEE subtype I-E or II viruses. Sneider JM; Kinney RM; Tsuchiya KR; Trent DW J Gen Virol; 1993 Mar; 74 ( Pt 3)():519-23. PubMed ID: 8445371 [TBL] [Abstract][Full Text] [Related]
35. [Variants of the Venezuelan equine encephalomyelitis virus resistant to the neutralizing action of monoclonal antibodies]. Agapov EV; Lebedeva SD; Razumov IA; Frolov IV; Kolykhalov AA; Loktev VB; Netesov SV; Sandakhchiev LS Dokl Akad Nauk SSSR; 1991; 320(6):1485-8. PubMed ID: 1804615 [No Abstract] [Full Text] [Related]